← back to search

Simeon Springer

Sidney Kimmel Comprehensive Cancer Center · US
Area of research
Cancer Research · Surgery
Research interest
Research interests include Bladder and Urothelial Cancer Treatments, Cancer-related molecular mechanisms research, Cancer Genomics and Diagnostics, and MicroRNA in disease regulation.
h-index
23
citations
6,926
works
66
NIH funding
primary concept
email

Recent publications

A multimodality test to guide the management of patients with a pancreatic cyst
Science Translational Medicine 2019cited by 205position: firstdoi
Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations
Gastroenterology 2019cited by 130position: middledoi
Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma
Modern Pathology 2019cited by 59position: middledoi
Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2019cited by 37position: middledoi
Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers
Science Translational Medicine 2018cited by 241position: middledoi
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
eLife 2018cited by 186position: firstdoi
Detection of aneuploidy in patients with cancer through amplification of long interspersed nucleotide elements (LINEs)
Proceedings of the National Academy of Sciences 2018cited by 65position: middledoi
Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations
Human Pathology 2018cited by 44position: middledoi
Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2017cited by 33position: middledoi
Bisulfite-converted duplexes for the strand-specific detection and quantification of rare mutations
Proceedings of the National Academy of Sciences 2017cited by 16position: middledoi
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Science Translational Medicine 2016cited by 1,458position: middledoi
Diagnostic potential of tumor DNA from ovarian cyst fluid
eLife 2016cited by 40position: middledoi
A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts
Journal of the American Medical Informatics Association 2016cited by 38position: middledoi
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
Science Translational Medicine 2015cited by 499position: middledoi
Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord
Proceedings of the National Academy of Sciences 2015cited by 472position: middledoi
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
Gastroenterology 2015cited by 456position: firstdoi
Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
Cancer Discovery 2014cited by 248position: middledoi
<i>TERT</i> Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine
Cancer Research 2013cited by 249position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Bert Vogelstein · Clinical Pharmacology of Miami8 papers (2013–2019)Nickolas Papadopoulos · Ludwig Cancer Research8 papers (2013–2019)Kenneth W. Kinzler · University of Baltimore7 papers (2013–2019)George J. Netto · University of Pennsylvania5 papers (2013–2019)Yuxuan Wang · Beijing Anzhen Hospital5 papers (2013–2018)Isaac Kinde · Detection Limit (United States)4 papers (2013–2018)Trinity J. Bivalacqua · Twitter (United States)4 papers (2013–2019)Maria Del Carmen Rodriguez Peña · University of Alabama at Birmingham4 papers (2017–2019)Diana Taheri · Johns Hopkins Medicine4 papers (2017–2019) · 3 papers (2017–2019)Kazutoshi Fujita · Lawrence Berkeley National Laboratory3 papers (2017–2019)Ralph H. Hruban · Occupational Cancer Research Centre3 papers (2013–2019)Marie‐Lisa Eich · Humboldt-Universität zu Berlin3 papers (2017–2019) · 3 papers (2017–2019)Stephania Martins Bezerra · Johns Hopkins Medicine2 papers (2017–2019)Anne Marie Lennon · University of Pittsburgh Medical Center2 papers (2018–2019)Joshua D. Cohen · Shaare Zedek Medical Center2 papers (2017–2018)Rachel Karchin · University of Baltimore2 papers (2018–2019)Isabela Werneck da Cunha · Friedrich-Alexander-Universität Erlangen-Nürnberg2 papers (2018–2019)Luis A. Díaz · Secretaria de Salud2 papers (2013–2016)